רטרוביר לאינפוזיה תוך ורידית Israel - ebraică - Ministry of Health

רטרוביר לאינפוזיה תוך ורידית

glaxo smith kline (israel) ltd - zidovudine - תמיסה לאינפוזיה - zidovudine 200 mg / 20 ml - zidovudine - zidovudine - retrovir iv for infusion is indicated for the short term management of serious manifestations of human immunodeficiency virus (hiv) infection in patients with acquired immuno deficiency syndrome (aids) or aids related complex (arc) who are unable to take retrovir oral formulations.

אפורציו IU 1000 Israel - ebraică - Ministry of Health

אפורציו iu 1000

salomon,levin & elstein ltd - epoetin theta (r-huepo) 1000 iu / 0.5 ml - solution for injection - erythropoietin - - treatment of symptomatic anaemia associated with chronic renal failure in adult patients.- treatment of symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.

אפורציו IU 2000 Israel - ebraică - Ministry of Health

אפורציו iu 2000

salomon,levin & elstein ltd - epoetin theta (r-huepo) 2000 iu / 0.5 ml - solution for injection - erythropoietin - - treatment of symptomatic anaemia associated with chronic renal failure in adult patients.- treatment of symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.

אפורציו IU 3000 Israel - ebraică - Ministry of Health

אפורציו iu 3000

salomon,levin & elstein ltd - epoetin theta (r-huepo) 3000 iu / 0.5 ml - solution for injection - erythropoietin - - treatment of symptomatic anaemia associated with chronic renal failure in adult patients.- treatment of symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.

אפורציו IU 4000 Israel - ebraică - Ministry of Health

אפורציו iu 4000

salomon,levin & elstein ltd - epoetin theta (r-huepo) 4000 iu / 0.5 ml - solution for injection - erythropoietin - - treatment of symptomatic anaemia associated with chronic renal failure in adult patients.- treatment of symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.

אפורציו IU 5000 Israel - ebraică - Ministry of Health

אפורציו iu 5000

salomon,levin & elstein ltd - epoetin theta (r-huepo) 5000 iu / 0.5 ml - solution for injection - erythropoietin - - treatment of symptomatic anaemia associated with chronic renal failure in adult patients.- treatment of symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.

אפורציו IU 10,000 Israel - ebraică - Ministry of Health

אפורציו iu 10,000

salomon,levin & elstein ltd - epoetin theta (r-huepo) 10000 iu / 1 ml - solution for injection - erythropoietin - - treatment of symptomatic anaemia associated with chronic renal failure in adult patients.- treatment of symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.

אפורציו IU 20,000 Israel - ebraică - Ministry of Health

אפורציו iu 20,000

salomon,levin & elstein ltd - epoetin theta (r-huepo) 20000 iu / 1 ml - solution for injection - erythropoietin - - treatment of symptomatic anaemia associated with chronic renal failure in adult patients.- treatment of symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.

אפורציו IU 30,000 Israel - ebraică - Ministry of Health

אפורציו iu 30,000

salomon,levin & elstein ltd - epoetin theta (r-huepo) 30000 iu / 1 ml - solution for injection - erythropoietin - - treatment of symptomatic anaemia associated with chronic renal failure in adult patients.- treatment of symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.

גונאל-אף 75 יחידות בינל (5.5 מקג) Israel - ebraică - Ministry of Health

גונאל-אף 75 יחידות בינל (5.5 מקג)

merck serono ltd - follitropin alfa - אבקה להכנת תמיסה לזריקה - follitropin alfa 5.5 mcg/dose - follitropin alfa - follitropin alfa - 1) gonal-f followed by chorionic gonadotrophin (hcg) is recommended for the stimulation of follicular development and ovulation in women with hypothalamic-pituitary dysfunction who present with either oligomenorrhoea or amenorrhoea. these women are classified as w.h.o group ii patients and usually receive clomiphene citrate as primary therapy. they have evidence of endogenous oestrogen production and thus will either spontaneously menstruate or experience withdrawal bleeding after progestagen administration. polycystic ovarian disease (pcod) is part of the who ii classification and is present in the majority of these patients. 2) gonal-f is indicated for stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertillization (ivf) gamete intra-fallopian transfer (gift) and zogote intra-fallopian transfer (zift). 3) gonal-f is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of sperma